Cullinan Therapeutics, Inc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINE8-KCullinan Therapeutics, Inc.CGEMOct 2

   Cullinan Therapeutics initiates NDA for zipalertinib

   • Submitted NDA for zipalertinib with chemotherapy for EGFR ex20ins NSCLC
   • Phase 3 trial met primary endpoint with improved progression-free survival
   • Expected NDA completion by end of 2026
2. ROUTINE8-KCullinan Therapeutics, Inc.CGEMSep 24

   Current report

3. ROUTINE8-KCullinan Therapeutics, Inc.CGEMSep 14

   Current report

4. ROUTINE4Cullinan Therapeutics, Inc.CGEMSep 10

   Jennifer Michaelson, insider filing for CGEM

   Jennifer Michaelson, reporting

5. ROUTINE144Cullinan Therapeutics, Inc.CGEMSep 8

   Jennifer Michaelson, planned sale of CGEM shares

   Jennifer Michaelson, reporting

6. ROUTINE4Cullinan Therapeutics, Inc.CGEMAug 14

   Jennifer Michaelson, insider filing for CGEM

   Jennifer Michaelson, reporting

7. ROUTINESCHEDULE 13G/ACullinan Therapeutics, Inc.CGEMAug 14

   Ownership stake disclosure by BIOTECHNOLOGY VALUE FUND L P (amended)

   BIOTECHNOLOGY VALUE FUND L P, filed by

8. ROUTINESCHEDULE 13GCullinan Therapeutics, Inc.CGEMAug 14

   Ownership stake disclosure by PRICE T ROWE ASSOCIATES INC /MD/

   PRICE T ROWE ASSOCIATES INC /MD/, filed by

9. ROUTINE144Cullinan Therapeutics, Inc.CGEMAug 13

   Jennifer Michaelson, planned sale of CGEM shares

   Jennifer Michaelson, reporting

10. ROUTINESCHEDULE 13GCullinan Therapeutics, Inc.CGEMAug 7

    Ownership stake disclosure by STATE STREET CORP

    STATE STREET CORP, filed by

11. NOTABLE10-QCullinan Therapeutics, Inc.CGEMAug 6

    Quarterly report

12. ROUTINE8-KCullinan Therapeutics, Inc.CGEMAug 6

    Current report

13. ROUTINE4Cullinan Therapeutics, Inc.CGEMJul 7

    Jennifer Michaelson, insider filing for CGEM

    Jennifer Michaelson, reporting

14. ROUTINE144Cullinan Therapeutics, Inc.CGEMJul 6

    Jennifer Michaelson, planned sale of CGEM shares

    Jennifer Michaelson, reporting

15. ROUTINE4Cullinan Therapeutics, Inc.CGEMJul 2

    2 insider filings

    Mary Kay Fenton, insider filing for CGEM

    Show all 2

    • 4Insider filing for CGEMJul 2
    • 4Insider filing for CGEMJul 2

    Mary Kay Fenton, reporting

16. ROUTINE4Cullinan Therapeutics, Inc.CGEMJun 18

    6 insider filings

    Anthony Rosenberg, insider filing for CGEM

    Show all 6

    • 4Insider filing for CGEMJun 18
    • 4Insider filing for CGEMJun 18
    • 4Insider filing for CGEMJun 18
    • 4Insider filing for CGEMJun 18
    • 4Insider filing for CGEMJun 18
    • 4Insider filing for CGEMJun 18

    Anthony Rosenberg, reporting

17. ROUTINE8-KCullinan Therapeutics, Inc.CGEMJun 16

    Current report

18. ROUTINE8-KCullinan Therapeutics, Inc.CGEMJun 10

    Current report

19. ROUTINE8-KCullinan Therapeutics, Inc.CGEMJun 8

    Current report

20. ROUTINE8-KCullinan Therapeutics, Inc.CGEMMay 18

    Current report

21. ROUTINESCHEDULE 13G/ACullinan Therapeutics, Inc.CGEMMay 15

    Ownership stake disclosure by BIOTECHNOLOGY VALUE FUND L P (amended)

    BIOTECHNOLOGY VALUE FUND L P, filed by

22. NOTABLE10-QCullinan Therapeutics, Inc.CGEMMay 7

    Quarterly report

23. ROUTINE8-KCullinan Therapeutics, Inc.CGEMMay 7

    Current report

24. ROUTINE4Cullinan Therapeutics, Inc.CGEMMay 6

    Jennifer Michaelson, insider filing for CGEM

    Jennifer Michaelson, reporting

25. ROUTINE144Cullinan Therapeutics, Inc.CGEMMay 5

    Jennifer Michaelson, planned sale of CGEM shares

    Jennifer Michaelson, reporting

26. ROUTINES-3ASRCullinan Therapeutics, Inc.CGEMApr 28

    Securities offering

27. ROUTINEDEFA14ACullinan Therapeutics, Inc.CGEMApr 28

    Additional proxy materials

28. ROUTINEDEF 14ACullinan Therapeutics, Inc.CGEMApr 28

    Proxy statement

29. ROUTINEARSCullinan Therapeutics, Inc.CGEMApr 28

    Annual report to shareholders

30. ROUTINESCHEDULE 13G/ACullinan Therapeutics, Inc.CGEMMar 26

    Ownership stake disclosure by VANGUARD GROUP INC (amended)

    VANGUARD GROUP INC, filed by

31. ROUTINES-8Cullinan Therapeutics, Inc.CGEMMar 10

    Employee stock plan registration

32. NOTABLE10-KCullinan Therapeutics, Inc.CGEMMar 10

    Annual report

33. ROUTINE8-KCullinan Therapeutics, Inc.CGEMMar 10

    Current report

34. ROUTINE4Cullinan Therapeutics, Inc.CGEMMar 9

    Jennifer Michaelson, insider filing for CGEM

    Jennifer Michaelson, reporting

35. ROUTINE144Cullinan Therapeutics, Inc.CGEMMar 5

    Jennifer Michaelson, planned sale of CGEM shares

    Jennifer Michaelson, reporting

36. ROUTINESCHEDULE 13GCullinan Therapeutics, Inc.CGEMMar 4

    Ownership stake disclosure by Kynam Capital Management, LP

    Kynam Capital Management, LP, filed by

37. ROUTINE4Cullinan Therapeutics, Inc.CGEMFeb 26

    Jennifer Michaelson, insider filing for CGEM

    Jennifer Michaelson, reporting

38. ROUTINE4Cullinan Therapeutics, Inc.CGEMFeb 25

    4 insider filings

    Jacquelyn L Sumer, insider filing for CGEM

    Show all 4

    • 4Insider filing for CGEMFeb 25
    • 4Insider filing for CGEMFeb 25
    • 4Insider filing for CGEMFeb 25
    • 4Insider filing for CGEMFeb 25

    Jacquelyn L Sumer, reporting

39. ROUTINE144Cullinan Therapeutics, Inc.CGEMFeb 25

    Jennifer Michaelson, planned sale of CGEM shares

    Jennifer Michaelson, reporting

40. ROUTINE4Cullinan Therapeutics, Inc.CGEMFeb 23

    2 insider filings

    Jeffrey Alan Jones, insider filing for CGEM

    Show all 2

    • 4Insider filing for CGEMFeb 23
    • 4Insider filing for CGEMFeb 23

    Jeffrey Alan Jones, reporting

Older filings on EDGAR